INTERNATIONAL PATENT: ALEXION PHARMACEUTICALS, INC. FILES APPLICATION FOR "IMMUNOSUPPRESSIVE THERAPY TO MITIGATE ANTI-SOLUBLE ALKALINE PHOSPHATASE IMMUNE RESPONSE"

GENEVA, Feb. 18 -- ALEXION PHARMACEUTICALS, INC. (121 Seaport BoulevardBoston, Massachusetts 02210) filed a patent application (PCT/US2024/040680) for "IMMUNOSUPPRESSIVE THERAPY TO MITIGATE ANTI-SOLUBLE ALKALINE PHOSPHATASE IMMUNE RESPONSE" on Aug 02, 2024. With publication no. WO/2025/034540, the details related to the patent application was published on Feb 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): FOURNIER, Tanya (c/o Alexion Pharmaceuticals, Inc.121 Seaport BoulevardBoston, Massachusetts 02210), PETRYK, Anna (c/o Alexion Pharmaceuticals, Inc.121 Seaport BoulevardBoston, Massach...